Aged Care: Valuation Support Versus Negative Momentum
Aged CareValuation Support versus Negative Momentum Omicron has arrived in NZ and with it an acceleration of the underperformance in the aged...
1.3k Views
Equity Strategy: The Year Ahead: Five Themes and Five Stocks
Equity StrategyThe Year Ahead: Five Themes and Five Stocks The long market bull run since the GFC appears to be ending as the structural decline...
1.4k Views
Arvida Group: 1H22 Result — Reinstate as OUTPERFORM
Arvida Group1H22 Result — Reinstate as OUTPERFORM OUTPERFORM We reinstate coverage of Arvida Group (ARV) with an OUTPERFORM rating and a 12 month...
979 Views
Arvida Group (ARV): 1H22 Result
Arvida Group (ARV)1H22 Result Arvida Group (ARV) reported a largely pre-announced 1H22 result (resales and new sales) with underlying profit of...
943 Views
Arvida Group: NZ$330m Capital Raise
Arvida GroupNZ$330m Capital Raise RESTRICTED Arvida Group (ARV) has announced a capital raise, totalling NZ$330m (NZ$155m underwritten placement...
260 Views